Cargando…

Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation

BACKGROUND: Galangin is believed to exert antioxidant effects by inhibition of the NLR family pyrin domain containing 3 (NLRP3) inflammasome, which has been linked to chemotherapy sensitivity in cancers. In this study, we explored the synergistic effect of galangin in combination with the chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Cong, Luo, Cui-Lian, Shang, Guan-Sheng, Jiang, De-Xiong, Song, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690210/
https://www.ncbi.nlm.nih.gov/pubmed/34916479
http://dx.doi.org/10.12659/MSM.931630
_version_ 1784618616687165440
author Zhang, Cong
Luo, Cui-Lian
Shang, Guan-Sheng
Jiang, De-Xiong
Song, Qi
author_facet Zhang, Cong
Luo, Cui-Lian
Shang, Guan-Sheng
Jiang, De-Xiong
Song, Qi
author_sort Zhang, Cong
collection PubMed
description BACKGROUND: Galangin is believed to exert antioxidant effects by inhibition of the NLR family pyrin domain containing 3 (NLRP3) inflammasome, which has been linked to chemotherapy sensitivity in cancers. In this study, we explored the synergistic effect of galangin in combination with the chemotherapy agent 5-fluorouracil (5-FU) in esophageal cancer cells and xenografts. MATERIAL/METHODS: The esophageal squamous epithelium cell line Het-1A and 2 human esophageal cancer cell lines (Eca109, OE19) were used to investigate the effect of galangin with or without 5-FU in vitro through proliferation and invasion analyses, while apoptosis was analyzed in cancer cells. Furthermore, a subcutaneous xenograft tumor model in mice was used to study cancer development in vivo. RESULTS: Compared with 5-FU monotherapy, combined galangin and 5-FU treatment reduced human esophageal cancer cell growth activities and invasion abilities. The results suggested that galangin had a chemotherapy-sensitized synergistic antitumor effect induced by 5-FU. The susceptibility of cancer cells to apoptosis, which is linked with chemotherapy sensitivity, was induced by 5-FU and further enhanced by galangin. NLRP3 was identified as being significantly activated by 5-FU, but galangin treatment reversed the effect and inhibited NLRP3 expression, which was accompanied by downregulated interleukin-1β levels. Further investigation showed that the induced apoptotic cascade can be mostly reversed by incubation with an NLRP3 activator, irrespective of AKT signaling. Using xenograft mouse models, we found that galangin exposure further restrained cancer development after 5-FU treatment and increased sensitivity to chemotherapy by suppressing the NLRP3 inflammasome pathway. CONCLUSIONS: Our results indicated that galangin played a synergistic anticancer role through NLRP3 inflammasome inhibition when paired with FU-5.
format Online
Article
Text
id pubmed-8690210
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-86902102022-01-19 Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation Zhang, Cong Luo, Cui-Lian Shang, Guan-Sheng Jiang, De-Xiong Song, Qi Med Sci Monit Animal Study BACKGROUND: Galangin is believed to exert antioxidant effects by inhibition of the NLR family pyrin domain containing 3 (NLRP3) inflammasome, which has been linked to chemotherapy sensitivity in cancers. In this study, we explored the synergistic effect of galangin in combination with the chemotherapy agent 5-fluorouracil (5-FU) in esophageal cancer cells and xenografts. MATERIAL/METHODS: The esophageal squamous epithelium cell line Het-1A and 2 human esophageal cancer cell lines (Eca109, OE19) were used to investigate the effect of galangin with or without 5-FU in vitro through proliferation and invasion analyses, while apoptosis was analyzed in cancer cells. Furthermore, a subcutaneous xenograft tumor model in mice was used to study cancer development in vivo. RESULTS: Compared with 5-FU monotherapy, combined galangin and 5-FU treatment reduced human esophageal cancer cell growth activities and invasion abilities. The results suggested that galangin had a chemotherapy-sensitized synergistic antitumor effect induced by 5-FU. The susceptibility of cancer cells to apoptosis, which is linked with chemotherapy sensitivity, was induced by 5-FU and further enhanced by galangin. NLRP3 was identified as being significantly activated by 5-FU, but galangin treatment reversed the effect and inhibited NLRP3 expression, which was accompanied by downregulated interleukin-1β levels. Further investigation showed that the induced apoptotic cascade can be mostly reversed by incubation with an NLRP3 activator, irrespective of AKT signaling. Using xenograft mouse models, we found that galangin exposure further restrained cancer development after 5-FU treatment and increased sensitivity to chemotherapy by suppressing the NLRP3 inflammasome pathway. CONCLUSIONS: Our results indicated that galangin played a synergistic anticancer role through NLRP3 inflammasome inhibition when paired with FU-5. International Scientific Literature, Inc. 2021-12-17 /pmc/articles/PMC8690210/ /pubmed/34916479 http://dx.doi.org/10.12659/MSM.931630 Text en © Med Sci Monit, 2021 https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Animal Study
Zhang, Cong
Luo, Cui-Lian
Shang, Guan-Sheng
Jiang, De-Xiong
Song, Qi
Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation
title Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation
title_full Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation
title_fullStr Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation
title_full_unstemmed Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation
title_short Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation
title_sort galangin enhances anticancer efficacy of 5-fluorouracil in esophageal cancer cells and xenografts through nlr family pyrin domain containing 3 (nlrp3) downregulation
topic Animal Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690210/
https://www.ncbi.nlm.nih.gov/pubmed/34916479
http://dx.doi.org/10.12659/MSM.931630
work_keys_str_mv AT zhangcong galanginenhancesanticancerefficacyof5fluorouracilinesophagealcancercellsandxenograftsthroughnlrfamilypyrindomaincontaining3nlrp3downregulation
AT luocuilian galanginenhancesanticancerefficacyof5fluorouracilinesophagealcancercellsandxenograftsthroughnlrfamilypyrindomaincontaining3nlrp3downregulation
AT shangguansheng galanginenhancesanticancerefficacyof5fluorouracilinesophagealcancercellsandxenograftsthroughnlrfamilypyrindomaincontaining3nlrp3downregulation
AT jiangdexiong galanginenhancesanticancerefficacyof5fluorouracilinesophagealcancercellsandxenograftsthroughnlrfamilypyrindomaincontaining3nlrp3downregulation
AT songqi galanginenhancesanticancerefficacyof5fluorouracilinesophagealcancercellsandxenograftsthroughnlrfamilypyrindomaincontaining3nlrp3downregulation